Barriers in the quest for quality drug information: Salutary lessons from TGA-approved sources for thyroid-related medications

Medical Journal of Australia

Volumn 186, Issue 2, 2007, Pages 76-79

  Stockigt, Jim R ^a,b,c  

^a EPWORTH HOSPITAL   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; IODIDE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROID EXTRACT; THYROXINE;

ACCURACY; BREAST FEEDING; CONSUMER; COOPERATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG MECHANISM; DRUG MILK LEVEL; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EUTHYROIDISM; EVIDENCE BASED PRACTICE; FETOTOXICITY; FIRST TRIMESTER PREGNANCY; GOITER; HEALTH CARE ORGANIZATION; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INFORMATION PROCESSING; LIVER DYSFUNCTION; LOW DRUG DOSE; MEDICAL LITERATURE; MEDICAL SPECIALIST; MYXEDEMA; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY CONTROL; RELIABILITY; REVIEW; THIRD TRIMESTER PREGNANCY; THYROIDECTOMY; THYROTOXICOSIS; VASCULITIS;

EID: 33846592875     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb00805.x     Document Type: Review

References (27)

1. Vanderpump MPJ, Tunbridge, WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
2. Pharmaceutical Benefits Schedule item statistics July 2004 - June 2005. http://www.medicareaustralia.gov.au/statistics/dyn_pbs/forms/ pbs_tab1.shtml (accessed Nov 2006).
3. MIMS annual. 30th ed. Sydney: CMPMedica Australia, 2006. (MIMS online incorporates information from both MIMS bi-monthly and MIMS annual. Subscription only. ).
4. Australian prescription products guide 2006. 35th ed. Sydney: Australian Pharmaceutical Publishing Company, 2006. (APPGuide Online 2007. Subscription only. ).
5. Pharmacy Board of Victoria. Guidelines for good pharmaceutical practice 2004 (incorporating 2005 amendments). Melbourne: PBV, 2005. http://www.pharmacybd.vic.gov.au/docs/guidelines_2004.pdf (accessed Nov 2006).
6. Pharmacists Board of Queensland. Information for pharmacists, http://www.pharmacyboard.qld.gov.au/Informationforpharmacists/ informationforpharmacists.htm (accessed Nov 2006).
7. Roti E, Minelli R, Gardini E, Braverman LE. The use and misuse of thyroid hormone. Endocr Rev 1993; 14: 401-423.
8. Therapeutic guidelines: endocrinology. Version 3. Melbourne: Therapeutic Guidelines Limited, 2004.
9. Speight TM, Holford NHG, editors. Avery's drug treatment. 4th ed. Auckland: Adis International, 1997.
10. De Groot LJ, Hennemann G, editors. Thyroid disease manager [online book]. http://www.thyroidmanager.org (accessed Nov 2006).
11. Sweetman SC. Martindale: the complete drug reference. 33rd ed. London: Pharmaceutical Press, 2002.
12. National Health and Medical Research Council. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Pilot program 2005-2007. http://www.nhmrc.gov.au/publications/files/ levels_grades05.pdf (accessed Nov 2006).
13. Toft A. Thyroxine therapy. N Engl J Med 1994; 331: 174-180.
14. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351: 241-249.
15. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
16. Cooper DS. Antithyroid drugs. N Engl J Med 2005; 352: 905-917.
17. Berghout A, Wiersinga WM, Drexhage HA, et al. Comparison of placebo with l-thyroxine alone or with carbimazole for treatment of sporadic nontoxic goitre. Lancet 1990; 336: 193-197.
18. Marcou K, Georgopoulos N, Kyriazopoulou V, et al. Iodine-induced hypothyroidism. Thyroid 2001; 11: 501-510.
19. Glinoer D. Thyroid regulation and dysfunction in the pregnant patient. In: De Groot LJ, Hennemann G, editors. Thyroid disease manager online book]. http://www.thyroidmanager.org/Chapter14/14-frame.htm (accessed Nov 2006).
20. Cooper DS. Antithyroid drugs. N Engl J Med 1984; 311: 1353-1362.
21. Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001; 86: 2354-2359.
22. Azizi F. Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism. J Endocrinol Invest 2003; 26: 301-304.
23. Rangaswamy M, Padhy AK, Gopinath PG, et al. Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism. Nucl Med Commun 1989; 10: 679-684.
24. Scholz GH, Hagemann E, Arkenau C, et al. Is there a place for thyroidectomy in older patients with thyrotoxic storm and cardiorespiratory failure? Thyroid 2003; 13: 933-940.
25. Laurberg P, Nohr SB. Iodine intake and prevention of thyroid disorders: surveillance is needed [editorial]. Med J Aust 2002, 176: 306-307.
26. Therapeutic Goods Administration. Initial discussion paper: improving access to prescription medicines information. Canberra: TGA, Apr 2005, http://www.tga.gov.au/consult/2005/accesspmi.pdf (accessed Nov 2006).
27. Therapeutic Goods Administration. Australian regulatory guidelines for prescription medicines. Appendix 12. Changes to the quality information of registered medicines: notification, self-assessment and prior approval. Canberra: Department of Health and Ageing, Jun 2004. http://www.tga.gov.au/pmeds/argpm.htm (accessed Nov 2006).